Evaluating dual direct-acting antivirals against persistent COVID-19

3D render of a medical background with DNA strands

Researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19).

Battery-Free Light-Powered Pacemaker Now a Reality

Previous article

Psilocybin could be a promising therapeutic strategy for people with treatment-resistant depression

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News